Arkolith/Insider Trading/ZSAN/Form 4

Matthews Christine

Chief Financial OfficerZosano Pharma Corp (ZSAN) · full profile →Form 4 · filed Apr 1, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2022Sell(S)8K$0.21$2K146K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-007911) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML